Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liquid Biopsies in the Clinical Management of Germ Cell Tumor Patients: State-of-the-Art and Future Directions
João Lobo, Ricardo Leão, Cármen Jerónimo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2654-2654
Open Access | Times Cited: 18

Showing 18 citing articles:

Risk Factors for Testicular Cancer: Environment, Genes and Infections—Is It All?
Sertaç Yazıcı, Dario Del Biondo, G. Napodano, et al.
Medicina (2023) Vol. 59, Iss. 4, pp. 724-724
Open Access | Times Cited: 37
MiRNA biomarkers in cancers of the male reproductive system: Are we approaching clinical application?
Vera Constâncio, Nuno Tiago Tavares, Rui Henrique, et al.
Andrology (2022) Vol. 11, Iss. 4, pp. 651-667
Closed Access | Times Cited: 23
A comprehensive overview of liquid biopsy applications in pediatric solid tumors
Ferdinand W. Janssen, Nathalie S.M. Lak, Claudia Y. Janda, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 4
DigiMir Test: Establishing a Novel Pipeline for MiR-371a Quantification Using Droplet Digital PCR in Liquid Biopsies From Testicular Germ Cell Tumor Patients
José Pedro Sequeira, João Lobo, Vera Constâncio, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 18
Biomarkers in Testicular Cancer
Jillian Egan, Keyan Salari
Urologic Clinics of North America (2022) Vol. 50, Iss. 1, pp. 133-143
Closed Access | Times Cited: 13
A stroll through the present and future of testicular germ cell tumour biomarkers
Nuno Tiago Tavares, Rui Henrique, Aditya Bagrodia, et al.
Expert Review of Molecular Diagnostics (2023) Vol. 23, Iss. 5, pp. 405-418
Closed Access | Times Cited: 7
Recent Advancements in Research on DNA Methylation and Testicular Germ Cell Tumors: Unveiling the Intricate Relationship
Alina-Teodora Nicu, Ileana Paula Ionel, Ileana Stoica, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1041-1041
Open Access | Times Cited: 2
The utility of cfDNA in TGCT patient management: a systematic review
Jure Krasić, Lucija Škara, Ana Katušić Bojanac, et al.
Therapeutic Advances in Medical Oncology (2022) Vol. 14, pp. 175883592210903-175883592210903
Open Access | Times Cited: 11
Molecular Biomarkers With Potential Clinical Application in Testicular Cancer
João Lobo, Andres Acosta, George J. Netto
Modern Pathology (2023) Vol. 36, Iss. 10, pp. 100307-100307
Closed Access | Times Cited: 6
Advancing clinical and translational research in germ cell tumours (GCT): recommendations from the Malignant Germ Cell International Consortium
Adriana Fonseca, João Lobo, Florette K. Hazard, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 9, pp. 1577-1583
Open Access | Times Cited: 9
CT Radiomics and Clinical Feature Model to Predict Lymph Node Metastases in Early-Stage Testicular Cancer
Catharina Silvia Lisson, Sabitha Manoj, Daniel Wolf, et al.
Onco (2023) Vol. 3, Iss. 2, pp. 65-80
Open Access | Times Cited: 4
Bone Metastases in Non-Seminomatous Germ Cell Tumors: A 20-Year Retrospective Analysis
R. Gille, Benoît Allignet, Floriane Izarn, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3280-3280
Open Access | Times Cited: 1
Current and Evolving Biomarkers in the Diagnosis and Management of Testicular Germ Cell Tumors
Jennifer Sykes, Alain Kaldany, Thomas L. Jang
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7448-7448
Open Access | Times Cited: 1
The anticancer effects of Metformin in the male germ tumor SEM-1 cell line are mediated by HMGA1
Alessandro Salatino, Maria Mirabelli, Eusebio Chiefari, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 7
Improving outcomes in germ cell cancers using miRNA
Ciara Conduit, Ben Tran
Therapeutic Advances in Medical Oncology (2021) Vol. 13
Open Access | Times Cited: 9
Carboxypeptidase N1 is anticipated to be a synergy metrics for chemotherapy effectiveness and prognostic significance in invasive breast cancer
Ranliang Cui, Chaomin Wang, Tiantian Li, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 7
(In)Distinctive Role of Long Non-Coding RNAs in Common and Rare Ovarian Cancers
Maja Sabol, Jean Calleja‐Agius, Riccardo Di Fiore, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5040-5040
Open Access | Times Cited: 6
CT Radiomics and Clinical Feature Model to Predict Lymph Node Metastases in Early-Stage Testicular Cancer
Catharina Silvia Lisson, Sabitha Manoj, Daniël De Wolf, et al.
(2023)
Open Access | Times Cited: 1
Page 1

Scroll to top